Notícias · Recifes

Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug str

A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new therapeutic approach that uses hydrogen peroxide (H₂O₂), a reactive oxygen species that damages cells and increases in the brains of patients with Alzheimer's

Admin Recifes 15/07/2026 2

Parkinson's patients undergoing deep brain stimulation show little to no cortical Lewy pat

Researchers at the Icahn School of Medicine at Mount Sinai have found that patients with Parkinson's disease undergoing deep brain stimulation (DBS) show little to no Lewy pathology in the prefrontal cortex at the time of their DBS surgery, despite often having longstanding, clin

Admin Recifes 15/07/2026 2

'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial

A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers showed. The findings, publis

Admin Recifes 15/07/2026 2

Two prostate cancer mutations reveal opposite responses to ferroptosis therapy

A new study by researchers at The University of Texas MD Anderson Cancer Center has identified genetic factors that determine whether prostate cancers are susceptible to a type of cell death known as ferroptosis. These findings, published in Nature Communications, could help guid

Admin Recifes 15/07/2026 2

EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic

For patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), adding pirtobrutinib to venetoclax-rituximab (PVR) yields improved progression-free survival (PFS) compared to venetoclax-rituximab (VR), according to a study presented at the annual congress of the E

Admin Recifes 15/07/2026 2

Dual-mobility hip replacement implant can lower dislocation risk by 70%

A new type of hip replacement implant reduces the risk of joint dislocation after surgery by 70%, according to a new study involving 1,600 patients across 44 hospitals in Sweden and the UK, published in The Lancet. The new implant consists of a small ball encased in a much larger

Admin Recifes 15/07/2026 2

Digital diabetes tool shown to improve patient care and cut health care costs

A new study by University of Manchester researchers has linked a digital platform helping people manage type 2 diabetes to better blood sugar control, improved health and potential long-term NHS cost savings. MyWay Diabetes, an NHS-supported online platform and app—which lets use

Admin Recifes 15/07/2026 2

Patients in Hawai'i spent $230M+ on out-of-state cancer care in 2021–2023, study finds

A new study led by researchers at the University of Hawaiʻi Cancer Center found that at least $230 million was spent on cancer care delivered outside Hawaiʻi between 2021 and 2023, highlighting the significant financial impact of geographic isolation on patients and the health ca

Admin Recifes 15/07/2026 2

New tumor map identifies high-risk B-cell lymphoma standard therapy may miss

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particula

Admin Recifes 15/07/2026 2

Decade-long national study finds antimicrobial use in Australian hospitals improves with r

A 10-year national study has found improved antimicrobial use in Australian hospitals that regularly monitored their prescribing, using a globally unique program developed by a Melbourne hospital. The study reinforces the importance of antimicrobial stewardship to improve patient

Admin Recifes 15/07/2026 2

AI tool improves prediction of who will respond to cancer immunotherapy drugs

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a k

Admin Recifes 15/07/2026 2

Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATR

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes